In this article, we are going to take a look at where Zymeworks Inc. (NASDAQ:ZYME) stands against other stocks that are receiving the most insider investment in March. “The economy is strong ...

Zymeworks Inc (NASDAQ:ZYME) is set to release its Q4 2024 earnings on Mar 5, 2025.The consensus estimate for Q4 2024 revenue is $45.20 million, and the earnings are expected to come in at -$0.03 ...

LifeSci Capital analyst Charles Zhu initiated coverage with a Buy rating on Zymeworks (ZYME – Research Report) today and set a price target of $30.00. The company’s shares closed yesterday at ...